|
Neoplasia
Citations 291-300 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma
- Manik Chatterjee, Christoph Rancso, Thorsten Stühmer, Niels Eckstein, Mindaugas Andrulis, Christian Gerecke, Heike Lorentz, Hans-Dieter Royer, and Ralf C. Bargou
Blood 2008; 111: 3714-3722.
[Abstract]
[Full text]
[PDF]
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells
- Ellen Weisberg, Lolita Banerji, Renee D. Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno, Laurence Catley, Jingrui Jiang, Elizabeth Hall-Meyers, Maira Sauveur-Michel, Richard Stone, Ilene Galinsky, Edward Fox, Andrew L. Kung, and James D. Griffin
Blood 2008; 111: 3723-3734.
[Abstract]
[Full text]
[PDF]
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
- Catherine Roche-Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, Nathalie Philippe, Sandrine Geffroy, Jean-Luc Laï, Franck-Emmanuel Nicolini, and Claude Preudhomme, on behalf of the Fi-LMC group
Blood 2008; 111: 3735-3741.
[Abstract]
[Full text]
[PDF]
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
- Bing Z. Carter, Duncan H. Mak, Wendy D. Schober, Martin F. Dietrich, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, and Michael Andreeff
Blood 2008; 111: 3742-3750.
[Abstract]
[Full text]
[PDF]
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
- Gerlinde Wernig, Jeffrey R. Gonneville, Brian J. Crowley, Margret S. Rodrigues, Mamatha M. Reddy, Heidi E. Hudon, Christoph Walz, Andreas Reiter, Klaus Podar, Yohan Royer, Stefan N. Constantinescu, Michael H. Tomasson, James D. Griffin, D. Gary Gilliland, and Martin Sattler
Blood 2008; 111: 3751-3759.
[Abstract]
[Full text]
[PDF]
Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis
- Jason G. Harb, Brenda I. Chyla, and Claudia S. Huettner
Blood 2008; 111: 3760-3769.
[Abstract]
[Full text]
[PDF]
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I–associated adult T-cell leukemia/lymphoma
- Georges Moarbess, Hiba El-Hajj, Youmna Kfoury, Marwan E. El-Sabban, Yves Lepelletier, Olivier Hermine, Carine Deleuze-Masquéfa, Pierre-Antoine Bonnet, and Ali Bazarbachi
Blood 2008; 111: 3770-3777.
[Abstract]
[Full text]
[PDF]
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
- Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Kaaren K. Reichard, Sara Tedoldi, Kevin Hollowood, Michael Dictor, Martin-Leo Hansmann, Stefano A. Pileri, Martin J. Dyer, Silvano Sozzani, Ivan Dikic, Andrey S. Shaw, Tony Petrella, Harald Stein, Peter G. Isaacson, Fabio Facchetti, and David Y. Mason
Blood 2008; 111: 3778-3792.
[Abstract]
[Full text]
[PDF]
HO-1 underlies resistance of AML cells to TNF-induced apoptosis
- Stuart A. Rushworth and David J. MacEwan
Blood 2008; 111: 3793-3801.
[Abstract]
[Full text]
[PDF]
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome
- Blaine W. Robinson, Nai-Kong V. Cheung, Christos P. Kolaris, Suresh C. Jhanwar, John K. Choi, Neil Osheroff, and Carolyn A. Felix
Blood 2008; 111: 3802-3812.
[Abstract]
[Full text]
[PDF]
|
|
